Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
3.4
-26x
20%
—
61.55%
Every year
—
5 Years
Score3.4
Net Growth-26x
Net Trend20%
Net Income Consistency—
Rev Growth61.55%
Rev TrendEvery year
Revenue Consistency—
Cytek Biosciences Inc fundamental performance
Between 2021 and 2025, revenue grew from $ 127M to $ 201M and net income went from $ 3M to -$ 66M. Revenue increased in 100% of the years measured; net income in 20%.
Cytek Biosciences Inc currently holds a 5-year HDB Score of 3.4 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 4.78 | — |
1 Year2025-08-12 | $ 4.03 | 18.61% |
5 Years2021-08-12 | $ 23.34 | -79.52% |
All Time2021-07-23 | $ 18.76 | -74.52% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-07-23 |
|---|---|---|---|---|
| Price | $ 4.78 | $ 4.03 | $ 23.34 | $ 18.76 |
| Return | — | 18.61% | -79.52% | -74.52% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 206M | -$ 80M | $ 262M |
| 2025 | $ 201M | -$ 66M | $ 261M |
| 2024 | $ 200M | -$ 6M | $ 277M |
| 2023 | $ 193M | -$ 12M | $ 262M |
| 2022 | $ 164M | $ 2M | $ 341M |
| IPO2021 | $ 127M | $ 3M | $ 364M |
Explore beyond CTKB
You're looking at Cytek Biosciences Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
